Advertisements



Sage Therapeutics, Shionogi partner on development of SAGE-217 in Asia

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 13th, 2018

Why Sage Therapeutics Is Booming

Sage Therapeutics, Inc. (NASDAQ: SAGE) shares made a handy gain on Tuesday after the firm announced its expedited development plan for SAGE-217 following a Breakthrough Therapy meeting with the U.S.........»»

Category: blogSource: 247wallstJun 12th, 2018

Commit To Buy Sage Therapeutics At $120, Earn 12.3% Using Options

Stock Options Channel.....»»

Category: topSource: redinewsJun 19th, 2018

Sage shares drop 3% after $90 mln Shionogi deal for key drug

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchJun 14th, 2018

Benzinga"s Daily Biotech Pulse: FDA Nods For Teligent And Keytruda, Sonoma"s Q4 Miss, Sage Inks Deal With Japan"s Shionogi

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling the Peaks (Stocks hit.....»»

Category: earningsSource: benzingaJun 14th, 2018

Benzinga"s Daily Biotech Pulse: FDA Nods For Teligent And Keytruda, Sonoma"s Q4 Miss, Sage Inks Deal With Japan"s Shionogi

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling the Peaks (Stocks hitting 52-week highs on June 13) read more.....»»

Category: blogSource: benzingaJun 14th, 2018

Sage Therapeutics price target raised to $220 from $210 at Canaccord

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 13th, 2018

Brainstorm Health: Alzheimer’s Drug Failures, Sage Therapeutics Stock, Azar on Drug Prices

Brainstorm Health Daily: June 12, 2018 Good afternoon, readers--This is Sy. Of the diseases that regularly afflict millions upon millions of Americans, few have been quite as nefarious as .....»»

Category: europeSource: fortuneJun 12th, 2018

Sage Therapeutics to hold a conference call

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 12th, 2018

Sage shares surge 4.5% on plan to expedite drug development for two types of depression

Sage Therapeu.....»»

Category: topSource: marketwatchJun 12th, 2018

Sage Therapeutics to host conference call

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 12th, 2018

Sage Therapeutics announces pivotal Phase 3 trial for SAGE-217

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 12th, 2018

Analyst: Sage Therapeutics Holds A Breakthrough In Depression Treatment

Sage Therapeutics Inc (NASDAQ: SAGE) is a buy ahead of the commercial launch of its safer alternatives to existing antidepressants, according to Ladenburg Thalmann. Latest Ratings for SAGE .....»»

Category: blogSource: benzingaJun 6th, 2018

Sage Therapeutics initiated with a Buy at Ladenburg

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 6th, 2018

Cormorant Asset Management, LLC Buys Nektar Therapeutics Inc, Sage Therapeutics Inc, Rocket ...

Related Stocks: NKTR, MRTX, TBPH, RETA, OMER, ASND, SAGE, RCKT, TSRO, VNDA,.....»»

Category: smallbizSource: nytMay 31st, 2018

Sage Therapeutics announces FDA acceptance for its NDA for PPD

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 30th, 2018

Sage Therapeutics pipeline programs on track, says BMO Capital

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 3rd, 2018

Sage Therapeutics sees cash, cash equivalents sufficient into 2020

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 3rd, 2018

Sage Therapeutics reports Q1 EPS ($1.68), consensus ($1.84)

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 3rd, 2018

Sage Therapeutics asks FDA to approve lead drug for postpartum depression

Cambridge-based Sage Therapeutics, one of the state’s most valuable biotechs, said Monday that it had formally asked the FDA to approve its lead drug, a treatment for postpartum depression. The filing of a new drug application, or NDA, marks an .....»»

Category: topSource: bizjournalsApr 23rd, 2018

Sage Therapeutics submits NDA for SAGE-547 for treatment of PPD

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: dealsSource: nytApr 23rd, 2018